Q-omics provides the consensus-scored IGHVII-67-1 profile across patient tissues and cancer cell-line models. IGHVII-67-1 expression is associated with patient survival in 5 of 34 cancer types, with the highest sampling consensus in CESC. Additionally, IGHVII-67-1 RNA expression shows 5,027 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight CESC, and STAD as cancer lineages where IGHVII-67-1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.